Tag: Clinical Trials
Many of the Initial COVID-19 Treatment Trials Poorly Designed
One-third of trials do not include clinical end points; 97 randomized trials were open-label design
Prostate Cancer Trial Participants Overwhelmingly White
Since 1990, proportion of white participants in prostate cancer clinical trials has remained >80 percent
COVID-19 Pandemic Slowing Cancer Research
Findings based on survey of American Cancer Society research grantees
Fewer Children Enrolling in Pediatric Cancer Trials
Adolescent and young adult cancer patients underrepresented in clinical trials
Impact of COVID-19 on Oncology Clinical Trials Discussed
Recommendations for sustaining cancer care access include permanent expanded support for telehealth
Adding High-Dose Chloroquine Not Advised for Severe COVID-19
High-dose versus low-dose group had higher lethality until day 13, more instances of QTc interval >500 ms
Premature Posting of Remdesivir Findings Were ‘Inconclusive’
Due to low enrollment, study was 'underpowered to enable statistically meaningful conclusions'
Enrollment Begins in NIH-Sponsored Trial of Remdesivir for COVID-19 Patients
Institutions also announce enrollment in study evaluating efficacy of sarilumab for hospitalized COVID-19 patients
Author Conflicts of Interest May Influence Cannabidiol Conclusions
Supportive conclusions seen in more studies with versus without CBD-related industry funding
Fewer Women in Cardiovascular Trials, but Representation Improving
Representation of women varies with disease and trial characteristics, but overall, men still dominate
